Understanding Key Drivers and Growth Opportunities in the Cancer Tumor Profiling Market: Trends and Market Size Insights
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Factors Are Propelling the Market Growth of theCancer Tumor Profiling Market from 2025 to 2034?
The rise in cancer cases worldwide is anticipated to fuel the expansion of the cancer and tumor profiling market. This surge is attributed to the uncontrollable growth and spread of certain body cells, a crucial character of cancer. Consequently, the rise in cancer instances is directly proportional to the need for cancer tumor profiling, as it allows medical practitioners to establish the disease’s severity. For example, the American Cancer Society, a U.S.-based professional body, recorded an increase from 1.9 million new cancer cases in 2023 to 2 million in 2024. Therefore, the escalating occurrence of cancer globally instigates the development of the cancer and tumor profiling market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6053&type=smp
#What Growth Opportunities Will Drive the Cancer Tumor Profiling Market’s CAGR Through 2034?
In recent times, there has been a swift expansion in the market size of cancer tumor profiling. It is projected to surge from $13 billion in 2024 to $14.99 billion in 2025, representing a compound annual growth rate (CAGR) of 15.3%. The notable growth during the historical period can be credited to factors such as the rising number of cancer cases, advancements in precision medicine activities and research partnerships, enhanced cancer diagnostic procedures and methods of early detection, the provision of a broad array of targeted treatment options, and favorable regulatory structures for cancer profiling tests.
In the coming years, the cancer tumor profiling market is predicted to experience significant expansion, escalating to a worth of $25.33 billion in 2029, with a compound annual growth rate (CAGR) of 14.0%. The projected growth during this period can be linked to the broadening of immunotherapy and immunoprofiling usage in cancer treatment, advancements in liquid biopsy and non-invasive tumor profiling techniques, increasing adoption of single-cell sequencing for comprehensive tumor analysis, enlargement of cancer screening and early detection initiatives, and growing demand for profiling of unusual and orphan cancer subtypes. Key market trends anticipated during this period include the incorporation of tumor profiling into standard clinical procedures, progress in multi-omics methodologies, the integration of artificial intelligence (AI) and machine learning in data analytics, the evolution of personalized medicine and targeted therapies, and the advancement in genomic and next-generation sequencing (NGS) technologies.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6053
How Are Market Trends and Innovations Revolutionizing theCancer Tumor Profiling Industry in Recent Times?
The surge in research and development undertakings is becoming a prevalent trend in the cancer and tumor profiling market. Esteemed companies in this sector are channeling their efforts into research and development activities to cater to customer needs and consolidate their market standing. For instance, QIAGEN N.V, a company based in Germany known for its sample and assay technology in applied testing, pharmaceutical development, molecular diagnostics, and academic research, publicized the CE-marking and commercial launch of the therascreen PIK3CA RGQ PCR Kit in Europe. This kit is a tool aimed at identifying breast cancer patients with mutations in the PIK3CA gene. The therascreen PIK3CA test is a diagnostic assay designed for detecting an activating mutation in the PIK3CA gene and it is the first of its kind that allows the testing of DNA derived from plasma samples or FFPE tissue.
Which Key Market Players Are Shaping the Future and Growth of theCancer Tumor Profiling Market?
Major companies operating in the cancer tumor profiling market include F. Hoffmann-La Roche Ltd., Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., Qiagen, Ribomed Biotechnologies Inc., HTG Molecular Diagnostics Inc., NanoString Technologies Inc., NeoGenomics Laboratories Inc., Lucence Health Inc., ACT Genomics Co. LTD, Strand Life Sciences, IMB Dx Inc., Exact Sciences Corporation, Guardant Health, Foundation Medicine Inc., Agilent Technologies Inc., Myriad Genetics Inc., Personal Genome Diagnostics Inc., Tempus Labs Inc., ArcherDX Inc., Natera Inc., Bio-Rad Laboratories Inc., Genetron Health, NantHealth Inc., Resolution Bioscience, Genomic Testing Cooperative, OncoDNA, Strata Oncology Inc., Genuity Science, RareCyte Inc., Inivata Limited, Cepheid
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report
What Are the Core Segments of the Cancer Tumor Profiling Market, and How Do They Contribute to Growth?
The cancer tumor profiling market covered in this report is segmented –
1) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies
3) By Process Type: Genomics, Proteomics, Epigenetics, Metabolomics, Other Types
4) By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications
Subsegments:
1) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)
2) By Breast Cancer: Hormone Receptor-Positive, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer
3) By Colorectal Cancer: Colon Cancer, Rectal Cancer
4) By Prostate Cancer: Localized Prostate Cancer, Advanced Prostate Cancer
5) By Melanoma: Cutaneous Melanoma, Non-Cutaneous Melanoma
6) By Ovarian Cancer: Epithelial Ovarian Cancer, Non-Epithelial Ovarian Cancer
7) By Stomach Cancer: Gastric Adenocarcinoma, Gastrointestinal Stromal Tumors (GISTs)
8) By Pancreatic Cancer: Exocrine Pancreatic Cancer, Neuroendocrine Tumors
9) By Thyroid Cancer: Papillary Thyroid Cancer, Follicular Thyroid Cancer, Medullary Thyroid Cancer
10) By Other Cancer Types: Kidney Cancer, Bladder Cancer, Liver Cancer, Esophageal Cancer
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=6053&type=smp
What Regions Are Dominating the Cancer Tumor Profiling Market Growth?
North America was the largest region in cancer and tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer tumor profiling market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Gobal Cancer Tumor Profiling Maret 2025, By The Business Research Company:
Cancer Clinical Decision Tools Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-clinical-decision-tool-global-market-report
Tumor Ablation Therapy Devices Global Market Report 2024
Cancer Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
